This company listing is no longer active
600385 Stock Overview
Shandong Jintai Group Co., Ltd. produces and distributes chemical reagent medicines in China.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Shandong Jintai Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥1.20 |
52 Week High | CN¥7.69 |
52 Week Low | CN¥0.88 |
Beta | 0.45 |
1 Month Change | -63.96% |
3 Month Change | -79.52% |
1 Year Change | -80.49% |
3 Year Change | -84.27% |
5 Year Change | -91.88% |
Change since IPO | -92.64% |
Recent News & Updates
Recent updates
Shareholder Returns
600385 | CN Luxury | CN Market | |
---|---|---|---|
7D | 0% | -1.6% | -0.03% |
1Y | -80.5% | -12.2% | -14.2% |
Return vs Industry: 600385 underperformed the CN Luxury industry which returned -19.1% over the past year.
Return vs Market: 600385 underperformed the CN Market which returned -8.1% over the past year.
Price Volatility
600385 volatility | |
---|---|
600385 Average Weekly Movement | n/a |
Luxury Industry Average Movement | 8.0% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.3% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 600385's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 600385's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 223 | Lin Yun | https://www.sdjintai.com.cn |
Shandong Jintai Group Co., Ltd. produces and distributes chemical reagent medicines in China. The company provides tablets, capsules, ointments, membranes, and others. It is also involved in the enterprise investment business, as well as in the provision of leasing services.
Shandong Jintai Group Co., Ltd. Fundamentals Summary
600385 fundamental statistics | |
---|---|
Market cap | CN¥177.73m |
Earnings (TTM) | CN¥4.81m |
Revenue (TTM) | CN¥64.94m |
36.9x
P/E Ratio2.7x
P/S RatioIs 600385 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600385 income statement (TTM) | |
---|---|
Revenue | CN¥64.94m |
Cost of Revenue | CN¥27.96m |
Gross Profit | CN¥36.98m |
Other Expenses | CN¥32.17m |
Earnings | CN¥4.81m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.032 |
Gross Margin | 56.95% |
Net Profit Margin | 7.41% |
Debt/Equity Ratio | 0.0% |
How did 600385 perform over the long term?
See historical performance and comparison